Performance of Different Resin Infiltration Materials on White Spot Lesions: Clinical and Laboratory Assessments

December 12, 2020 updated by: Jumanah Aljishi, Imam Abdulrahman Bin Faisal University
The study is a clinical controlled trial. Ethical approval will be obtained from Imam Abdulrahman bin Faisal University, Dammam. The study participants will be recruited from the dental hospital and conducted between November 2020 to November 2020. This will be a single-center, randomized, single blinded with a 1:1:1 allocation ratio for the application of Icon® resin infiltration, MI Paste Plus and both treatments

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Anticipated)

7

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dammam, Saudi Arabia, 32437
        • Imam Abdulrahman Bin Faisal University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients who are willing and able to observe good oral hygiene and attend for the study visits.
  • Subjects with ≥1 visible and accessible early caries lesion present.
  • No prior white spot lesion treatment utilized except tooth brushing with fluoridated toothpaste.

Exclusion Criteria:

  • Active carious lesions
  • Facial surface restorations
  • Deciduous teeth
  • Enamel alteration (fluorosis, opacity, hypocalcification, hypoplasia)
  • Intrinsic and extrinsic strains
  • Physically and mentally challenged volunteers
  • Patients with systemic diseases under medication
  • Smokers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group 2
s a superior form of fluoride ions as it also contains CPP-ACP, enhances mineral release without encouraging the formation of calculus.
Experimental: Group 1
low viscosity resin that can flow through the pores in the enamel surface
Active Comparator: Group 3
low viscosity resin that can flow through the pores in the enamel surface
s a superior form of fluoride ions as it also contains CPP-ACP, enhances mineral release without encouraging the formation of calculus.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Color improvements
Time Frame: Change from 0 day, 1 month and 6 months
Pre-treatment and post-treatment color changing (L*A*B values) of digital photographs using the Commission Internationale de l'Eclairage (CIE) system
Change from 0 day, 1 month and 6 months
Patient self satisfaction
Time Frame: Change from 0 day, 1 month and 6 months
Post-treatment patient satisfaction using the patient satisfaction scale
Change from 0 day, 1 month and 6 months
Change in lesion status
Time Frame: Change from 0 day, 1 month and 6 months
Post-treatment change in caries lesion status using ICDAS II
Change from 0 day, 1 month and 6 months
Cracks of enamel.
Time Frame: Change from 0 day, 1 month and 6 months
Number of cracks assessed by enamel surface analysis via silicone replicas using CLSM
Change from 0 day, 1 month and 6 months
Microbial composition.
Time Frame: Change from 0 day, 1 month and 6 months
Pre-treatment and post-treatment microbial composition of plaque samples. Samples will be stored at -80 °C until DNA extractions will be performed and run the 16S rRNA sequencing.
Change from 0 day, 1 month and 6 months
Effects on clinical parameter: sensitivity to percussion
Time Frame: Change from 0 day, 1 month and 6 months
Pre-treatment and post-treatment effects on sensitivity to percussion by end blunted instrument.
Change from 0 day, 1 month and 6 months
esthetic improvement
Time Frame: Change from 0 day, 1 month and 6 months
Esthetic improvement through objective assessments using a visual analogue
Change from 0 day, 1 month and 6 months
Patient esthetic self perception
Time Frame: Change from 0 day, 1 month and 6 months
Pre-treatment esthetic self perception by the subjects using questionnaire
Change from 0 day, 1 month and 6 months
change in lesion size
Time Frame: Change from 0 day, 1 month and 6 months
Pre-treatment and post-treatment white spot lesion size
Change from 0 day, 1 month and 6 months
fracture of enamel.
Time Frame: Change from 0 day, 1 month and 6 months
Number of fracture assessed by enamel surface analysis via silicone replicas using CLSM
Change from 0 day, 1 month and 6 months
Effects on clinical parameter: prolonged response to hot or cold.
Time Frame: Change from 0 day, 1 month and 6 months
Pre-treatment and post-treatment effects on response to hot or cold by cold test
Change from 0 day, 1 month and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

December 19, 2020

Primary Completion (Anticipated)

November 30, 2022

Study Completion (Anticipated)

November 30, 2022

Study Registration Dates

First Submitted

October 10, 2020

First Submitted That Met QC Criteria

December 12, 2020

First Posted (Actual)

December 17, 2020

Study Record Updates

Last Update Posted (Actual)

December 17, 2020

Last Update Submitted That Met QC Criteria

December 12, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • IAU_resin

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on White Spot Lesion

Clinical Trials on Icon® resin infiltration

3
Subscribe